tazemetostat Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Epizyme, Inc. (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadsystemic therapy

I am/have/hadlymphoma

I am/have/hadbone marrow procedure

I am/have/hadrenal function

I am/have/hadchemoimmunotherapy

I am/have/hadexperimental therapy

I am/have/hadcancer therapy

I am/have/hadbilateral oophorectomy

I am/have/hadhysterectomy

I am/have/hadtubal ligation

I am/have/hadfollicular lymphoma

I am/have/hadrenal function test

I am/have/hadmeasurable disease

I am/have/hadsystemic chemotherapy

I am/have/hadinvestigational treatment

I am/have/hadhuman chorionic gonadotropin

I am/have/hadrefractory follicular lymphoma

I am/have/hadtotal body irradiation

I am/have/hadvasectomy

I am/have/hadhepatitis

added new label for I am/have/had

more

I am looking for

I am looking formonoclonal antibodies

I am looking forrevlimid

I am looking fortositumomab

I am looking forrituximab

I am looking forhepatitis b surface antigen

I am looking fornitrosoureas

I am looking forhuman chorionic gonadotropin

I am looking foribritumomab tiuxetan

I am looking formonoclonal protein

I am looking fortazemetostat

I am looking forbeta human chorionic gonadotropin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study in Subjects With Relapsed/Refractory Follicular Lymphoma

This is a multicenter, double-blind, active-controlled, randomized, 3-stage, biomarker enrichment design featuring early futility stopping and sample-size re-estimation with safety run-in designed to evaluate the efficacy and safety of tazemetostat in combination with R2 in subjects with R/R FL, who have completed at least 1 prior systemic chemotherapy, immunotherapy, or …

monoclonal antibodies

systemic therapy

revlimid

rituximab

lymphoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.